Leading the Way in Life Science Technologies

GEN Exclusives

More »

Oct. 1, Vol. 33, No. 17

    • Columns

      • Advertorial: AbbVie Contract Manufacturing
      • AbbVie continues a legacy reflecting more than a century at the forefront of pharmaceutical development and manufacturing. For 25 years, AbbVie Contract Manufacturing has offered contract manufacturing services that today comprise biologics, potent, ... more »
      • Advertorial: Advanced BioScience Laboratories (ABL)
      • ABL is a contract research and manufacturing service provider, specializing in the development of vaccines and biotherapeutics for preclinical and clinical studies. For more than 50 years, the discoveries made in ABL’s laboratories have offered insi ... more »
      • Advertorial: Cell Sciences
      • Cell Sciences’ laboratories produce quality immunochemicals and hematology reagents for life science research. Our pipeline provides products for use within the research, biotechnology, and biopharmaceutical communities. Our goal is to provide our c ... more »
      • Advertorial: Corning Life Sciences
      • Corning offers a comprehensive range of innovative, high-quality tools and solutions for life science research and bioproduction. All Corning brands offer consistent, reliable, and repeatable results giving you the confidence that you can only get f ... more »
      • Advertorial: Douglas Scientific
      • When Douglas Scientific entered the laboratory automation scene in 2009, it was uncertain if the startup company could achieve the disruptive outcomes it proclaimed. Within four short years the Array Tape™ Platform has inspired an industry-wide para ... more »
      • Advertorial: Florida Biologix
      • Florida Biologix is a preclinical and Phase I/II biologics contract development, manufacturing, and testing organization (CDMO) focused on a wide range of value-optimizing services, such as process development, cell banking (cGMP), vector and vaccin ... more »
      • Advertorial: Fujifilm Diosynth Biotechnologies
      • Fujifilm Diosynth Biotechnologies is an industry leading biologics contract development and manufacturing organization with a strong track record in process development, refinement, and technology transfer of biopharmaceuticals, from preclinical thr ... more »
      • Advertorial: OriGene Technologies
      • OriGene Technologies was founded in 1996 as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. OriGene’s mission, to prepare comprehensive sets of gene r ... more »
      • Advertorial: Promega
      • Promega’s portfolio includes more than 2,500 products covering the fields of genomics, proteomics, cellular analysis, drug discovery, and genetic identity, reflecting 35 years of experience providing solutions for scientists. We continue to invest i ... more »
      • Advertorial: United States Pharmacopeial Convention
      • The United States Pharmacopeial Convention (USP) is dedicated to improving the health of people around the world through public standards and related products and services that help ensure the quality, safety, and benefit of medicines. As biologic d ... more »
      • Cord Blood for Cellular Therapy
      • Enal Razvi, Ph.D.
      • Cellular therapy is a challenging discipline from a variety of perspectives: The cells themselves need to be prepared and proven to be the appropriate inoculum free of contaminating subpopulations; there need to be assays to demonstrate, safety, eff ... more »
      • Events Advertorial: Pittcon 2014
      • Pittcon is the world’s largest annual conference and exposition for laboratory science. This year’s dynamic event will be in Chicago, Illinois, at McCormick Place, March 2–6, 2014. Pittcon offers something for everyone—a robust educational experienc ... more »
      • FDA Speeds Things Up
      • Patricia Fitzpatrick Dimond, Ph.D.
      • The Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law on July 9, 2012. FDASIA section 902 provided for a development path, the breakthrough therapy designation, for new drugs. Since last July, the agency has receive ... more »
      • HIV Researchers Seek a Potential Cure
      • Gail Dutton
      • HIV research has reached the point that a cure may be possible. “HIV is a complicated disease, and it’s very encouraging to see advancements,” says Elizabeth Wolffe, Ph.D., Sangamo BioSciences spokesperson. “We’ve seen antiretroviral therapies that ... more »
      • Prepping for the Clinic
      • Gail Dutton
      • BioLineRx is a drug development company focused on advancing research products into the clinic. The company was formed in 2003 to bring Israeli biotech to global attention, but has since expanded its interests and now in-licenses preclinical and ear ... more »
    • Feature Articles

      • CROs: Is Yours Meeting Your Needs?
      • Zach Hartman
      • Contract research organizations (CROs) have developed into a burgeoning support industry for pharmaceutical companies and biotechs since they gained a foothold in the late 1980s and into the 1990s. Now, CROs represent a multibillion dollar industr ... more »
      • Human Disease Models Move Underwater
      • Nsikan Akpan, Ph.D.
      • From Ilya Mechnikov discovering phagocytosis in starfish larvae to Hodgkin and Huxley defining the principles of nerve conduction in the giant axons of squid, aquatic animal models have influenced our understanding of human biology for over 100 year ... more »
      • PMT-Based Hit Picking for HCA
      • Peter Banks, Ph.D.
      • High-content analysis (HCA) describes the use of automated fluorescence microscopy and a wide array of fluorescent probes for the study of fixed or live cells, tissues, or even whole organisms, where quantitative phenotypic data is obtained from ima ... more »

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »